Anebulo Pharmaceuticals, Inc. (ANEB): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

33.82M
Year ended 2025-06-30
+13.2%
3-year compound annual growth
2022-06-30: 23.34M2023-06-30: 25.07M2024-06-30: 25.82M2025-06-30: 33.82M33.82M
2022-06-30 Weighted Average Diluted Shares (shares) 2025-06-30
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-06-3033.82M+31.0%2025-09-29, From 2024-07-01
2024-06-3025.82M+3.0%2025-09-29, From 2023-07-01
2023-06-3025.07M+7.4%2024-09-25, From 2022-07-01
2022-06-3023.34Mn/a2023-09-22, From 2021-07-01